GENTA INCORPORATED /DE/
4, 1998-01-16
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: INDIVIDUAL INVESTOR GROUP INC, SC 13D, 1998-01-16
Next: AIM INTERNATIONAL FUNDS INC, 497, 1998-01-16



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Walner, David 
   c/o Paramount Capital, Inc.
   787 Seventh Avenue
   New York, NY  10019
2. Issuer Name and Ticker or Trading Symbol
   GENTA INCORPORATED /DE/
   GNTA
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   01/16/98
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director ( ) 10% Owner ( ) Officer (give title below) (X) Other
   (specify below)
   See Footnote 1
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
Series D Convertible P|$0.94375|12/30|J(2)| |922        |A  |12/31|N/A  |Common Stock|97,745 |(2)    |922         |D(2|            |
referred Stock(2)     |        |/97  |    | |           |D  |/97  |     |            |       |       |            |)  |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Class D Warrants(2)   |$0.94375|12/30|J(2)| |4,612      |A  |12/31|6/30/|Common Stock|4,612  |(2)    |4,612       |D(2|            |
                      |        |/97  |    | |           |D  |/97  |02   |            |       |       |            |)  |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1)  Mr. Walner disclaims status as an officer of the Company under Rule 16a-2 
     and is making this filing voluntarily.
(2)  The Series D Preferred  Stock and Class D Warrants are  components of units
     ("Units")  issuable upon exercise of warrants  ("Unit  Purchase  Warrants")
     exerciseable  from  December  30,  1997 to June  30,  2002,  at an  initial
     exercise price of $110,000 per Unit. Mr. Walner may be deemed  beneficially
     to own Unit  Purchase  Warrants to purchase an aggregate  of .92246  Units.
     Each Unit  consists,  initially,  of (i) 1,000 shares of Series D Preferred
     Stock of the  Issuer,  par value  $0.001 per share,  and (ii) 5,000 Class D
     Warrants.   the  Unit  Purchase  Warrants  contain  certain   anti-dilution
     adjustments.  On December  29,  1997,  Paramount  Capital  Inc.  designated
     recipients  (the  "Paramount  Warrant  Designees")  of  the  Unit  Purchase
     Warrants. Mr. Walner was among the Paramount Warrant Designees and received
     such Unit Purchase  Warrants in connection  with a private  placement  (the
     "Private  Placement")  of  securities  of the  Issuer  of  which  Paramount
     Capital, Inc. acted as placement agent.

SIGNATURE OF REPORTING PERSON
/s/ David Walner
- ----------------
David Walner
DATE
01/16/98


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission